Radiotherapy Devices Market Current Scenario Trends, Comprehensive Analysis and Regional Forecast to 2032

 According to a recent Future Market Insights publication titled By the end of 2022, the market for radiation equipment is projected to be worth US$ 6.4 billion, and from 2022 to 2032, it will grow at a CAGR of 10.3%. By the end of 2032, the market is predicted to be worth US$ 17.0 Bn. In 2021, the global market for external beam radiation therapy Devices had a share of about 82.0%.

Cancer is diagnosed and treated with radiation, primarily x-rays, through radiotherapy. Radiation therapy can be used to treat a wide variety of cancers. It can also be used in combination with other cancer treatments, including chemotherapy and/or surgery.

Key drivers fuelling revenue growth of the global radiotherapy devices market

Rising instances of cancer across the globe: The adoption of western lifestyles and rise in unhealthy habits such as smoking, lack of physical activity, poor diet, etc. in economically developing countries will place a huge burden of cancer across the global populace. The demand for radiotherapy as a treatment option will be bolstered as a result.

Patient preference for minimally invasive techniques: Patients suffering from cancer, especially breast cancer (the second most common cancer in the world) are showing an increasing preference for minimally invasive treatment techniques and this is anticipated to fuel the growth in demand for radiotherapy.

Request Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1556

Growing popularity of radiotherapy devices among oncologists: Radiation therapy being the most popular therapy type in cancer management, oncologists across the world are showing an inclination towards radiotherapy devices, given the fact that more than 50% of cancer patients are likely to receive radiotherapy during the course of their treatment – either in primary disease management or for symptom control.

Global Radiotherapy Devices Market – Current Scenario & Future Outlook

The current scenario of the global radiotherapy devices market indicates a growing demand for radiotherapy devices in developing countries owing to ease of regulations and increasing product affordability. The radiotherapy devices market is highly consolidated with companies offering innovative products with latest technological advancements.

The future market outlook leans on minimally non-invasive technology that will generate the necessary demand in the global market. Among regions, North America will rule the global market for radiotherapy devices. Technological advancements coupled with growing instances of different types of cancers will make the global radiotherapy devices market a lucrative destination for investors.

Global Radiotherapy Devices Market: Segmental Forecast

The global radiotherapy devices market is segmented on the basis of product type into External Beam Radiotherapy Devices (sub-segmented into Linear Accelerators Devices and Proton Therapy Devices) and Internal Beam Radiotherapy Devices (sub-segmented into Brachytherapy); on the basis of end user into Hospitals, Ambulatory Surgical Centres, and Oncological Treatment Centres; and on the basis of region into North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan, Japan, and Middle East & Africa.

By product type, External Beam Radiotherapy Devices will dominate the global radiotherapy devices market in terms of value share, estimated to hold over 75% market share in 2017 and over 85% market share by the end of the forecast period in 2027. This segment will register a high CAGR of 10.7% during the forecast period.

Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-1556

By end user, Hospitals will retain a dominant position in the global radiotherapy devices market with an estimated market valuation in excess of US$ 6,500 Mn by the end of 2027. Oncological Treatment Centres will hold the runner-up position, registering a CAGR of 8.7% during the forecast period.

Among the regional markets, North America will retain its pole position in the global market with a Y-o-Y growth rate of 8.1% in 2018 over 2017. Latin America will witness sluggish growth throughout the forecast period, with a CAGR of 6.4% recorded between 2017 and 2027.

Global Radiotherapy Devices Market: Competition Dashboard

The Future Market Insights report profiles some of the leading companies operating in the global radiotherapy devices market including Varian Medical Systems, Elekta AB, Accuray, Inc., C.R. Bard, Inc., IBA Ion Beam Applications SA, Koninklijke Philips N.V., Siemens AG, Eckert & Ziegler Bebig, IsoRay, Inc., GE Healthcare, Vision RT Ltd., RaySearch Laboratories AB, Theragenics Corp, Toshiba Medical Systems Corporation, AngioDynamics, Inc., Mitsubishi Electric Corporation, Shinva Medical Instrument Company Limited, and Neusoft Medical Systems Co., Ltd.

Key Segments Covered in Radiotherapy Devices Market Report

By Product:

• External Beam Radiation Therapy Devices
• Linear Accelerators Devices
• Proton Therapy Devices
• Internal Beam Radiation Therapy Devices
• Brachytherapy Devices
• Others

By End User:

• Hospitals
• Ambulatory Surgical Centers
• Oncological Treatment Centers

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa (MEA)

Ask an Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-1556